NO953657D0 - Nytt farmasöytisk produkt - Google Patents

Nytt farmasöytisk produkt

Info

Publication number: NO953657D0
Authority: NO; Norway
Prior art keywords: pharmaceutical product; new pharmaceutical; new; product; pharmaceutical
Prior art date: 1994-09-19

Application number

NO953657A

Other languages

English (en)

Other versions

NO953657L (no

NO308107B1 (no

Inventor

Labell Elizabeth Smith

Wayne Douglas Luke

John Mcneill Mcgill

Randal Scot Miller

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-19

Filing date

1995-09-15

Publication date

1995-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26976194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO953657(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-09-19 Priority claimed from US08/308,325 external-priority patent/US5629425A/en

1995-09-15 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1995-09-15 Publication of NO953657D0 publication Critical patent/NO953657D0/no

1996-03-20 Publication of NO953657L publication Critical patent/NO953657L/no

2000-07-24 Publication of NO308107B1 publication Critical patent/NO308107B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO953657A 1994-09-19 1995-09-15 Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel NO308107B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/308,325 US5629425A (en)	1994-09-19	1994-09-19	Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US42791495A	1995-04-26	1995-04-26

Publications (3)

Publication Number	Publication Date
NO953657D0 true NO953657D0 (no)	1995-09-15
NO953657L NO953657L (no)	1996-03-20
NO308107B1 NO308107B1 (no)	2000-07-24

Family

ID=26976194

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19953658A NO313996B1 (no)	1994-09-19	1995-09-15	Krystallinsk solvat av forbindelsen 6-hydroksy-2-(4- hydroksyfenyl)-3-[4-(2-piperidinoetoksy)benzoyl]benzo[b]tiofenhydroklorid, fremgangsmåtefor fremstilling av solvatet, og fremgangsmåte for fremstilling av en ikke-solvatisert utgaveav forbind
NO953657A NO308107B1 (no)	1994-09-19	1995-09-15	Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO19953658A NO313996B1 (no)	1994-09-19	1995-09-15	Krystallinsk solvat av forbindelsen 6-hydroksy-2-(4- hydroksyfenyl)-3-[4-(2-piperidinoetoksy)benzoyl]benzo[b]tiofenhydroklorid, fremgangsmåtefor fremstilling av solvatet, og fremgangsmåte for fremstilling av en ikke-solvatisert utgaveav forbind

Country Status (50)

Country	Link
US (4)	US6472531B1 (no)
JP (2)	JPH08193081A (no)
KR (2)	KR100367376B1 (no)
CN (2)	CN1075069C (no)
AP (1)	AP754A (no)
AT (2)	AT407988B (no)
AU (3)	AU691955B2 (no)
BE (2)	BE1009625A3 (no)
BG (1)	BG62793B1 (no)
BR (2)	BR9504060A (no)
CA (2)	CA2158400C (no)
CH (3)	CH691125A5 (no)
CO (2)	CO4410191A1 (no)
CZ (2)	CZ290343B6 (no)
DE (3)	DE19549755B4 (no)
DK (4)	DK175903B1 (no)
EE (1)	EE03386B1 (no)
EG (1)	EG23763A (no)
ES (2)	ES2109882B1 (no)
FI (2)	FI121424B (no)
FR (2)	FR2732020B1 (no)
GB (2)	GB2293382B (no)
GE (1)	GEP19991821B (no)
GR (2)	GR1002709B (no)
HR (2)	HRP950482B1 (no)
HU (2)	HU225417B1 (no)
IE (2)	IE80883B1 (no)
IL (3)	IL125283A (no)
IS (1)	IS1788B (no)
IT (2)	IT1277602B1 (no)
LU (2)	LU88660A1 (no)
LV (2)	LV11178B (no)
MY (1)	MY116371A (no)
NL (2)	NL1001196C2 (no)
NO (2)	NO313996B1 (no)
NZ (2)	NZ280027A (no)
OA (1)	OA10406A (no)
PE (2)	PE32796A1 (no)
PL (2)	PL187686B1 (no)
PT (2)	PT101770B (no)
RO (2)	RO115260B1 (no)
RS (2)	RS49578B (no)
SE (2)	SE520721C2 (no)
SI (2)	SI9500292A (no)
SK (1)	SK283502B6 (no)
TR (1)	TR199501136A2 (no)
TW (1)	TW412534B (no)
UA (2)	UA42716C2 (no)
UY (1)	UY24040A1 (no)
WO (1)	WO1996009045A1 (no)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE38968E1 (en)	1992-07-28	2006-02-07	Eli Lilly And Company	Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
USRE39049E1 (en)	1992-07-28	2006-03-28	Eli Lilly And Company	Methods for inhibiting bone loss
TW366342B (en) *	1992-07-28	1999-08-11	Lilly Co Eli	The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5478847A (en)	1994-03-02	1995-12-26	Eli Lilly And Company	Methods of use for inhibiting bone loss and lowering serum cholesterol
CO4410191A1 (es) *	1994-09-19	1997-01-09	Lilly Co Eli	SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US6458811B1 (en) *	1996-03-26	2002-10-01	Eli Lilly And Company	Benzothiophenes formulations containing same and methods
EA001257B1 (ru) *	1996-03-26	2000-12-25	Эли Лилли Энд Компани	Бензотиофены, содержащие их фармацевтические композиции и способы лечения патологических состояний с их использованием
ZA992858B (en)	1996-10-30	1999-07-29	Lilly Co Eli	Methods of preventing breast cancer.
CA2236254A1 (en) *	1997-04-30	1998-10-30	David Warren Hoard	Process for preparing benzo¬b\|thiophenes
MXPA01011227A (es)	1999-05-04	2002-07-02	Strakan Ltd	Glicosidas androgenas y su actividad androgenica.
US6921827B2 (en) *	2000-11-27	2005-07-26	Eli Lilly And Company	Process for preparing 3-aryl-benzo{b} thiophenes
CN1649614A (zh)	2002-02-22	2005-08-03	新河药品股份有限公司	活性剂传递系统和保护及施用活性剂的方法
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EP1546138B1 (en)	2002-09-30	2012-01-18	A/S GEA Farmaceutisk Fabrik	Raloxifene l-lactate or a hemihydrate thereof, their uses, pharmaceutical compositions and preparation processes
US6861422B2 (en)	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20060106010A1 (en) *	2003-05-27	2006-05-18	Black Larry J	Methods for inhibiting bone loss
US7501426B2 (en)	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004029784A1 (de)	2004-06-21	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004030502A1 (de)	2004-06-24	2006-01-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
DE102004033670A1 (de)	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060058311A1 (en)	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
US20060035903A1 (en)	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US7728134B2 (en)	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en)	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
US20060074088A1 (en)	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
EP1630163A1 (de)	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CA2581843C (en)	2004-09-29	2012-05-15	Bayer Healthcare Ag	Thermodynamically stable form of bay 43-9006 tosylate
US20060068010A1 (en) *	2004-09-30	2006-03-30	Stephen Turner	Method for improving the bioavailability of orally delivered therapeutics
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102004058337A1 (de)	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
DE102005035891A1 (de)	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US7439358B2 (en)	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
PE20110235A1 (es)	2006-05-04	2011-04-14	Boehringer Ingelheim Int	Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
CN101437823B (zh)	2006-05-04	2014-12-10	勃林格殷格翰国际有限公司	多晶型
AR062927A1 (es)	2006-10-11	2008-12-17	Bayer Healthcare Ag	4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
WO2008047105A1 (en) *	2006-10-17	2008-04-24	Cipla Limited	Crystalline form of benzothiophene compound and process for preparation thereof
US20080103295A1 (en) *	2006-10-25	2008-05-01	David Losan Ho	Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst
US8258291B2 (en) *	2006-10-25	2012-09-04	Mamtek International Limited	Process for the preparation of sucralose by the chlorination of sugar with triphosgene (BTC)
DE102007032451B4 (de)	2007-07-12	2010-09-30	Icfs Gmbh	Verfahren zur Herstellung von aromatischen Ketonen
US20090023799A1 (en) *	2007-07-20	2009-01-22	George Laurence	CRYSTALS OF (2-AMINO-4,5,6,7-TETRAHYDROBENZO[b]THIEN-3-YL)(4-CHLOROPHENYL)METHANONE
EP2185559A1 (en)	2007-08-03	2010-05-19	Boehringer Ingelheim International GmbH	Crystalline form of a dihydropteridione derivative
CL2008003799A1 (es) *	2007-12-21	2009-12-18	Synthon Bv	Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis.
PE20140960A1 (es)	2008-04-03	2014-08-15	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
US20110088613A1 (en) *	2008-06-09	2011-04-21	Massimo Ferrari	Process for controlling the growth of a raloxifene hydrochloride crystal
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko)	2008-08-06	2019-02-18	베링거 인겔하임 인터내셔날 게엠베하	메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
JP2012502081A (ja)	2008-09-10	2012-01-26	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	糖尿病及び関連症状の治療のための組み合わせ治療
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
US8865729B2 (en)	2008-12-23	2014-10-21	Boehringer Ingelheim International Gmbh	Salt forms of a xanthine compound
TW201036975A (en)	2009-01-07	2010-10-16	Boehringer Ingelheim Int	Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
EP2448562B1 (en)	2009-07-02	2013-11-06	Synthon B.V.	Raloxifene composition
EP2314581B1 (en)	2009-10-23	2012-07-25	Hexal AG	A process for preparing benzo[b]thiophene derivatives
WO2011064352A1 (en)	2009-11-27	2011-06-03	Boehringer Ingelheim International Gmbh	Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011099942A1 (en)	2010-02-09	2011-08-18	Silverstone Pharma	New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
MX366325B (es)	2010-05-05	2019-07-05	Boehringer Ingelheim Int	Terapia de combinacion.
CN102971005A (zh)	2010-06-24	2013-03-13	贝林格尔.英格海姆国际有限公司	糖尿病治疗
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
IT1403083B1 (it) *	2010-10-25	2013-10-04	Fidia Farmaceutici	Nuova forma polimorfa di raloxifene cloridrato
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US9358233B2 (en)	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors
EP2731947B1 (en)	2011-07-15	2019-01-16	Boehringer Ingelheim International GmbH	Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
EP2849755A1 (en)	2012-05-14	2015-03-25	Boehringer Ingelheim International GmbH	A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
JP6218811B2 (ja)	2012-05-14	2017-10-25	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ZA201401636B (en)	2013-03-05	2014-11-26	Cipla Ltd	Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
US20150031699A1 (en)	2013-07-26	2015-01-29	Boehringer Ingelheim International Gmbh	Treatment of myelodysplastic syndrome
EP3110449B1 (en)	2014-02-28	2023-06-28	Boehringer Ingelheim International GmbH	Medical use of a dpp-4 inhibitor
US9867831B2 (en)	2014-10-01	2018-01-16	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
CN104496963A (zh) *	2014-12-02	2015-04-08	千辉药业（安徽）有限责任公司	一种盐酸雷洛昔芬的制备方法
US10155000B2 (en)	2016-06-10	2018-12-18	Boehringer Ingelheim International Gmbh	Medical use of pharmaceutical combination or composition
KR102815172B1 (ko) *	2020-02-25	2025-05-29	엘지전자 주식회사	히트펌프 및 그 동작방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3869485A (en) *	1969-09-25	1975-03-04	Allied Chem	Preparation of acid chlorides with phosgene in the presence of a catalyst
GB1456323A (en) *	1974-06-06	1976-11-24	Labaz	Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US4133814A (en)	1975-10-28	1979-01-09	Eli Lilly And Company	2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
ZA822247B (en)	1981-04-03	1983-11-30	Lilly Co Eli	Benzothiophene compounds and process for preparing them
PH18628A (en)	1981-04-03	1985-08-23	Lilly Co Eli	"6-hydroxy-2-(4-hydroxyphenyl)-3 4-(2- piperidine or 3-methylpyrollidine -benzo b thiophene compounds
IL65378A (en) *	1981-04-03	1986-02-28	Lilly Co Eli	Process for preparing 3-(4-aminoethoxybenzoyl)benzo-(b)thiophenes
US4418068A (en) *	1981-04-03	1983-11-29	Eli Lilly And Company	Antiestrogenic and antiandrugenic benzothiophenes
US4358593A (en) *	1981-04-03	1982-11-09	Eli Lilly And Company	Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
US4380635A (en) *	1981-04-03	1983-04-19	Eli Lilly And Company	Synthesis of acylated benzothiophenes
IL65379A0 (en) *	1981-04-03	1982-05-31	Lilly Co Eli	Process for preparing acylated benzothiophenes
DE4117512A1 (de) *	1991-05-25	1992-11-26	Schering Ag	2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JP3157882B2 (ja) *	1991-11-15	2001-04-16	帝国臓器製薬株式会社	新規なベンゾチオフエン誘導体
US5169860A (en)	1992-03-13	1992-12-08	Eli Lilly And Company	Antitumor compositions and methods of treatment
TW383306B (en)	1992-12-22	2000-03-01	Lilly Co Eli	New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
ES2105525T3 (es) *	1993-06-24	1997-10-16	Lilly Co Eli	2-fenil-3-aroilbenzotiofenos antiestrogenicos como agentes hipoglicemicos.
US6756388B1 (en) *	1993-10-12	2004-06-29	Pfizer Inc.	Benzothiophenes and related compounds as estrogen agonists
US5523416A (en)	1994-07-22	1996-06-04	Eli Lilly And Company	Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
CO4410191A1 (es) *	1994-09-19	1997-01-09	Lilly Co Eli	SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS

1995
- 1995-06-02 CO CO95023870A patent/CO4410191A1/es unknown
- 1995-06-02 CO CO95023869A patent/CO4410190A1/es unknown
- 1995-06-05 TW TW084105613A patent/TW412534B/zh not_active IP Right Cessation
- 1995-06-06 US US08/469,961 patent/US6472531B1/en not_active Expired - Lifetime
- 1995-06-06 US US08/467,485 patent/US5731327A/en not_active Expired - Lifetime
- 1995-06-06 US US08/469,093 patent/US6399778B1/en not_active Expired - Fee Related
- 1995-06-07 PE PE1995270673A patent/PE32796A1/es not_active IP Right Cessation
- 1995-06-07 PE PE1995270674A patent/PE14796A1/es not_active Application Discontinuation
- 1995-09-13 ES ES09501774A patent/ES2109882B1/es not_active Revoked
- 1995-09-13 ES ES009501775A patent/ES2129293B1/es not_active Expired - Fee Related
- 1995-09-14 UA UA95094169A patent/UA42716C2/uk unknown
- 1995-09-14 IL IL12528395A patent/IL125283A/en not_active IP Right Cessation
- 1995-09-14 UA UA95094168A patent/UA44240C2/uk unknown
- 1995-09-14 IL IL11531595A patent/IL115315A/xx not_active IP Right Cessation
- 1995-09-14 NL NL1001196A patent/NL1001196C2/nl active Search and Examination
- 1995-09-14 NL NL1001194A patent/NL1001194C2/nl active Search and Examination
- 1995-09-14 IL IL11531495A patent/IL115314A/xx not_active IP Right Cessation
- 1995-09-15 CZ CZ19952403A patent/CZ290343B6/cs not_active IP Right Cessation
- 1995-09-15 RO RO95-01620A patent/RO115260B1/ro unknown
- 1995-09-15 IT IT95MI001936A patent/IT1277602B1/it active IP Right Grant
- 1995-09-15 PT PT101770A patent/PT101770B/pt not_active IP Right Cessation
- 1995-09-15 CA CA002158400A patent/CA2158400C/en not_active Expired - Lifetime
- 1995-09-15 IT IT95MI001935A patent/IT1277601B1/it active IP Right Grant
- 1995-09-15 NO NO19953658A patent/NO313996B1/no not_active IP Right Cessation
- 1995-09-15 KR KR1019950030209A patent/KR100367376B1/ko not_active Expired - Lifetime
- 1995-09-15 RO RO95-01619A patent/RO115259B1/ro unknown
- 1995-09-15 PT PT101771A patent/PT101771B/pt not_active IP Right Cessation
- 1995-09-15 CA CA002158399A patent/CA2158399C/en not_active Expired - Lifetime
- 1995-09-15 NO NO953657A patent/NO308107B1/no not_active IP Right Cessation
- 1995-09-15 NZ NZ280027A patent/NZ280027A/en not_active IP Right Cessation
- 1995-09-15 DK DK199501027A patent/DK175903B1/da not_active IP Right Cessation
- 1995-09-15 UY UY24040A patent/UY24040A1/es not_active IP Right Cessation
- 1995-09-15 NZ NZ280028A patent/NZ280028A/en not_active IP Right Cessation
- 1995-09-15 SE SE9503213A patent/SE520721C2/sv not_active IP Right Cessation
- 1995-09-15 CZ CZ19952402A patent/CZ292007B6/cs not_active IP Right Cessation
- 1995-09-15 KR KR1019950030210A patent/KR100381346B1/ko not_active Expired - Lifetime
- 1995-09-15 DK DK199501028A patent/DK175897B1/da not_active IP Right Cessation
- 1995-09-15 SE SE9503214A patent/SE509265C2/sv not_active IP Right Cessation
- 1995-09-17 EG EG76395A patent/EG23763A/xx active
- 1995-09-18 BE BE9500760A patent/BE1009625A3/fr active
- 1995-09-18 GB GB9519028A patent/GB2293382B/en not_active Expired - Fee Related
- 1995-09-18 FI FI954403A patent/FI121424B/fi not_active IP Right Cessation
- 1995-09-18 HU HU9502721A patent/HU225417B1/hu not_active IP Right Cessation
- 1995-09-18 HU HU9502723A patent/HU227683B1/hu not_active IP Right Cessation
- 1995-09-18 CN CN95118629A patent/CN1075069C/zh not_active Expired - Lifetime
- 1995-09-18 HR HR950482A patent/HRP950482B1/xx not_active IP Right Cessation
- 1995-09-18 GR GR950100341A patent/GR1002709B/el not_active IP Right Cessation
- 1995-09-18 AU AU31730/95A patent/AU691955B2/en not_active Expired
- 1995-09-18 CN CN95118449A patent/CN1068324C/zh not_active Expired - Lifetime
- 1995-09-18 CH CH02629/95A patent/CH691125A5/de not_active IP Right Cessation
- 1995-09-18 HR HR950483A patent/HRP950483B1/xx not_active IP Right Cessation
- 1995-09-18 JP JP7238209A patent/JPH08193081A/ja active Pending
- 1995-09-18 MY MYPI95002762A patent/MY116371A/en unknown
- 1995-09-18 FR FR9510922A patent/FR2732020B1/fr not_active Expired - Fee Related
- 1995-09-18 AU AU31731/95A patent/AU692907B2/en not_active Ceased
- 1995-09-18 AT AT0154295A patent/AT407988B/de not_active IP Right Cessation
- 1995-09-18 SI SI9500292A patent/SI9500292A/sl not_active IP Right Cessation
- 1995-09-18 LV LVP-95-285A patent/LV11178B/en unknown
- 1995-09-18 BR BR9504060A patent/BR9504060A/pt not_active IP Right Cessation
- 1995-09-18 BE BE9500761A patent/BE1009626A3/fr active
- 1995-09-18 GB GB9519032A patent/GB2293602B/en not_active Expired - Fee Related
- 1995-09-18 BR BR9504059A patent/BR9504059A/pt not_active IP Right Cessation
- 1995-09-18 FI FI954402A patent/FI112226B/fi not_active IP Right Cessation
- 1995-09-18 GR GR950100340A patent/GR1002697B/el not_active IP Right Cessation
- 1995-09-18 FR FR9510921A patent/FR2724655B1/fr not_active Expired - Fee Related
- 1995-09-18 LU LU88660A patent/LU88660A1/fr unknown
- 1995-09-18 JP JP7238211A patent/JP2860071B2/ja not_active Expired - Lifetime
- 1995-09-18 CH CH01780/00A patent/CH691594A5/de not_active IP Right Cessation
- 1995-09-18 AT AT0154395A patent/AT502957A1/de not_active Application Discontinuation
- 1995-09-18 LV LVP-95-284A patent/LV11177B/en unknown
- 1995-09-18 LU LU88661A patent/LU88661A1/fr unknown
- 1995-09-18 CH CH02628/95A patent/CH691478A5/de not_active IP Right Cessation
- 1995-09-18 SI SI9500293A patent/SI9500293A/sl not_active IP Right Cessation
- 1995-09-19 IE IE950721A patent/IE80883B1/en not_active IP Right Cessation
- 1995-09-19 GE GEAP19953626A patent/GEP19991821B/en unknown
- 1995-09-19 RS YUP-613/95A patent/RS49578B/sr unknown
- 1995-09-19 RS YU61495A patent/RS49513B/sr unknown
- 1995-09-19 SK SK233-97A patent/SK283502B6/sk not_active IP Right Cessation
- 1995-09-19 DE DE19549755A patent/DE19549755B4/de not_active Expired - Fee Related
- 1995-09-19 AP APAP/P/1997/000938A patent/AP754A/en active
- 1995-09-19 AU AU37186/95A patent/AU3718695A/en not_active Abandoned
- 1995-09-19 PL PL95310517A patent/PL187686B1/pl not_active IP Right Cessation
- 1995-09-19 DE DE19534745A patent/DE19534745B4/de not_active Expired - Fee Related
- 1995-09-19 DE DE19534744A patent/DE19534744A1/de not_active Ceased
- 1995-09-19 IE IE950722A patent/IE950722A1/en not_active IP Right Cessation
- 1995-09-19 WO PCT/US1995/011872 patent/WO1996009045A1/en active Application Filing
- 1995-09-19 EE EE9700055A patent/EE03386B1/xx unknown
- 1995-09-19 PL PL95310518A patent/PL182450B1/pl not_active IP Right Cessation
- 1995-09-19 TR TR95/01136A patent/TR199501136A2/xx unknown
1997
- 1997-01-09 DK DK199700028A patent/DK175886B1/da not_active IP Right Cessation
- 1997-01-09 DK DK199700027A patent/DK175887B1/da not_active IP Right Cessation
- 1997-02-18 BG BG101242A patent/BG62793B1/bg unknown
- 1997-03-18 IS IS4446A patent/IS1788B/is unknown
- 1997-03-19 OA OA60977A patent/OA10406A/en unknown
2002
- 2002-02-26 US US10/083,179 patent/US20020173645A1/en not_active Abandoned

Also Published As

Publication number	Publication date
GB9519028D0 (en)	1995-11-15
DK175887B1 (da)	2005-05-23
CA2158399A1 (en)	1996-03-20
RS49513B (sr)	2006-10-27
YU61495A (sh)	1998-05-15
ES2129293A1 (es)	1999-06-01
CH691478A5 (de)	2001-07-31
PL182450B1 (pl)	2002-01-31
SK23397A3 (en)	1997-08-06
EE9700055A (et)	1997-08-15
PT101771B (pt)	1997-04-30
NO953658D0 (no)	1995-09-15
JPH08193081A (ja)	1996-07-30
NL1001194A1 (nl)	1996-03-19
NL1001196C2 (nl)	1997-04-04
SI9500292A (en)	1996-06-30
DE19534745A1 (de)	1996-04-04
LV11177A (lv)	1996-04-20
KR100381346B1 (ko)	2004-04-13
DE19534745B4 (de)	2004-06-09
DK102795A (da)	1996-03-20
GR1002709B (el)	1997-06-04
SI9500293A (en)	1996-06-30
GB2293602A (en)	1996-04-03
HUT75033A (en)	1997-03-28
PL310518A1 (en)	1996-04-01
NO953658L (no)	1996-03-20
CO4410190A1 (es)	1997-01-09
CN1075069C (zh)	2001-11-21
RS49578B (sr)	2007-04-10
SE9503213L (sv)	1996-03-20
PE14796A1 (es)	1996-05-19
UA42716C2 (uk)	2001-11-15
IL115314A0 (en)	1996-05-14
CA2158399C (en)	2001-03-20
ITMI951935A1 (it)	1997-03-15
NO953657L (no)	1996-03-20
JPH08176147A (ja)	1996-07-09
US20020173645A1 (en)	2002-11-21
YU61395A (sh)	1998-09-18
AU3173195A (en)	1996-04-04
LV11177B (en)	1996-08-20
DK175903B1 (da)	2005-06-06
AU3718695A (en)	1996-04-09
CH691125A5 (de)	2001-04-30
IL115314A (en)	2000-02-29
NZ280028A (en)	1997-05-26
GR1002697B (el)	1997-05-22
UA44240C2 (uk)	2002-02-15
LV11178A (lv)	1996-04-20
SE9503214D0 (sv)	1995-09-15
GB2293382B (en)	1998-08-19
TR199501136A2 (tr)	1996-06-21
CH691594A5 (de)	2001-08-31
ES2109882B1 (es)	1998-08-16
BE1009625A3 (fr)	1997-06-03
HRP950483B1 (en)	2003-02-28
DK175897B1 (da)	2005-05-30
AT502957A1 (de)	2007-06-15
BE1009626A3 (fr)	1997-06-03
BG62793B1 (bg)	2000-08-31
IT1277602B1 (it)	1997-11-11
IS1788B (is)	2001-11-28
DK2897A (da)	1997-01-09
CN1068324C (zh)	2001-07-11
PT101770B (pt)	1997-04-30
AU691955B2 (en)	1998-05-28
CO4410191A1 (es)	1997-01-09
IL115315A0 (en)	1995-12-31
GEP19991821B (en)	1999-11-05
CZ292007B6 (cs)	2003-07-16
CZ240295A3 (en)	1996-04-17
JP2860071B2 (ja)	1999-02-24
CA2158400C (en)	2006-10-24
KR100367376B1 (ko)	2003-03-06
CN1132205A (zh)	1996-10-02
AP9700938A0 (en)	1997-04-30
NL1001194C2 (nl)	1997-04-04
DK2797A (da)	1997-01-09
SE9503213D0 (sv)	1995-09-15
IT1277601B1 (it)	1997-11-11
KR960010634A (ko)	1996-04-20
FI954403A7 (fi)	1996-03-20
FR2724655A1 (fr)	1996-03-22
FI112226B (fi)	2003-11-14
PL187686B1 (pl)	2004-09-30
SE509265C2 (sv)	1998-12-21
BG101242A (en)	1998-03-31
IE950721A1 (en)	1996-03-20
NL1001196A1 (nl)	1996-03-19
HUT74178A (en)	1996-11-28
FI954403A0 (fi)	1995-09-18
FR2732020B1 (fr)	1997-11-14
DE19549755B4 (de)	2005-05-04
ES2109882A1 (es)	1998-01-16
HU227683B1 (en)	2011-11-28
LU88661A1 (fr)	1996-07-15
AT407988B (de)	2001-07-25
IE80883B1 (en)	1999-05-19
NZ280027A (en)	1997-05-26
SE9503214L (sv)	1996-03-20
UY24040A1 (es)	1996-03-07
ITMI951935A0 (it)	1995-09-15
IL125283A (en)	2001-06-14
OA10406A (en)	2001-12-05
TW412534B (en)	2000-11-21
CZ290343B6 (cs)	2002-07-17
US6472531B1 (en)	2002-10-29
ATA154295A (de)	2000-12-15
LU88660A1 (fr)	1996-07-15
BR9504059A (pt)	1996-09-24
HU9502723D0 (en)	1995-11-28
FR2732020A1 (fr)	1996-09-27
AP754A (en)	1999-07-22
CA2158400A1 (en)	1996-03-20
WO1996009045A1 (en)	1996-03-28
EG23763A (en)	2007-08-08
NO313996B1 (no)	2003-01-13
FI954402L (fi)	1996-03-20
DK175886B1 (da)	2005-05-23
FR2724655B1 (fr)	1997-11-14
BR9504060A (pt)	1996-09-24
HU9502721D0 (en)	1995-11-28
IS4446A (is)	1997-03-18
LV11178B (en)	1996-08-20
AU3173095A (en)	1996-04-04
EE03386B1 (et)	2001-04-16
IL115315A (en)	1999-09-22
HRP950483A2 (en)	1997-10-31
SE520721C2 (sv)	2003-08-12
GB2293602B (en)	1998-05-06
SK283502B6 (sk)	2003-08-05
MY116371A (en)	2004-01-31
RO115260B1 (ro)	1999-12-30
NO308107B1 (no)	2000-07-24
PL310517A1 (en)	1996-04-01
GB2293382A (en)	1996-03-27
HRP950482A2 (en)	1998-02-28
IE950722A1 (en)	1996-03-20
KR960010637A (ko)	1996-04-20
AU692907B2 (en)	1998-06-18
US5731327A (en)	1998-03-24
GB9519032D0 (en)	1995-11-15
HU225417B1 (en)	2006-11-28
HK1019009A1 (en)	2000-01-14
DE19534744A1 (de)	1996-03-21
ITMI951936A0 (it)	1995-09-15
PT101771A (pt)	1996-04-30
ITMI951936A1 (it)	1997-03-15
US6399778B1 (en)	2002-06-04
PT101770A (pt)	1996-04-30
ES2129293B1 (es)	2000-01-16
FI121424B (fi)	2010-11-15
DK102895A (da)	1996-03-20
RO115259B1 (ro)	1999-12-30
FI954402A0 (fi)	1995-09-18
CZ240395A3 (en)	1996-04-17
PE32796A1 (es)	1996-08-07
HRP950482B1 (en)	2007-04-30
CN1127253A (zh)	1996-07-24

Publication	Publication Date	Title
NO953657D0 (no)	1995-09-15	Nytt farmasöytisk produkt
DE69408033D1 (de)	1998-02-26	Absorbierendes Produkt
FI973243L (fi)	1997-08-06	Uusi farmaseuttinen yhdistelmä
FI970995L (fi)	1997-04-25	Farmaseuttisia yhdisteitä
FI971018L (fi)	1997-04-18	Farmaseuttisia yhdisteitä
DE69602606D1 (de)	1999-07-01	Verkapseltes produkt
DK72793D0 (da)	1993-06-21	Nyt produkt
DE69426294D1 (de)	2000-12-21	Rehydrierbares produkt
FI954243A7 (fi)	1996-03-13	Farmaseuttiset yhdisteet
DE69419295D1 (de)	1999-08-05	Zweifach gegossenes Produkt
DE69620098D1 (de)	2002-05-02	Zwei Ansichten zeigendes Produkt
DE69629671D1 (de)	2003-10-02	Netzbares produkt
BR9610214A (pt)	1999-06-15	Compostos farmacéuticos
DK0813586T3 (da)	2000-02-28	Mugfjernelsesprodukt
DK0672350T3 (da)	2001-09-17	Vand-kontinuert smørbart produkt
DE69820861D1 (de)	2004-02-05	Teilchenförmige arzneimittelträger
DK86492D0 (da)	1992-06-30	Laegemiddel
DE59807753D1 (de)	2003-05-08	Schellackhaltiges kosmetisches produkt
NO975436D0 (no)	1997-11-26	Laminært produkt
DK0864255T3 (da)	2003-09-22	Vandkontinuerligt smørbart produkt
ATE245984T1 (de)	2003-08-15	Kristallines pharmazeutisches produkt
FI973230L (fi)	1997-08-05	Uusi farmaseuttinen formulaatio
NO965448D0 (no)	1996-12-18	Farmasöytiske forbindelser
FI950472A0 (fi)	1995-02-02	Foerfarande foer framstaellning av en konstgjord produkt och skinnprodukt
FI942803A0 (fi)	1994-06-13	Ipsapironi-lääkevalmiste

Legal Events

Date	Code	Title	Description
2015-04-27	MM1K	Lapsed by not paying the annual fees